Light + Negative Ion Therapy for Depression
Trial Summary
What is the purpose of this trial?
Antidepressants are widely used as first-line treatments for major depressive disorder (MDD). Clinical guidelines recommend 6-24 months of "maintenance" antidepressant treatment, after patients achieve symptom remission, to prevent relapse but many people stop antidepressants too soon relapse into another depressive episode. We will test non-medication treatments, negative ion therapy and light therapy, to see they can substitute for antidepressants to prevent relapse. This is a "feasibility" study to see if participants use study treatments properly, before doing a larger, definitive trial. In this 28-week study, 100 participants with MDD who are in remission with antidepressants will be treated with light therapy or negative ion therapy (with half of devices active and half inactive) while slowly discontinuing the antidepressant, and monitored for relapse.
Will I have to stop taking my current medications?
Yes, participants will need to slowly stop taking their current antidepressant medication during the study while using light or negative ion therapy.
What data supports the effectiveness of this treatment for depression?
Research shows that high-density negative air ions can reduce symptoms of seasonal affective disorder, with 58% of participants experiencing significant improvement. Bright light therapy has also been effective for winter depression, and both treatments have shown promise for non-seasonal depression.12345
Is Light + Negative Ion Therapy safe for humans?
How does Light + Negative Ion Therapy for Depression differ from other treatments for depression?
This treatment is unique because it combines light therapy with exposure to negative air ions, which are believed to have beneficial health effects by altering the electrical charge of air molecules. Unlike traditional antidepressants, this approach uses natural elements to potentially improve mood and emotional state.89101112
Research Team
Raymond W Lam, MD
Principal Investigator
University of British Columbia
Eligibility Criteria
This trial is for adults with recurrent major depressive disorder (MDD) who are in remission thanks to antidepressants and want to stop their medication due to side effects or other reasons. They must meet specific criteria, have been on a stable dose of antidepressants, and be willing to do self-reports in English or French. People with significant personality disorders, high suicide risk, recent substance abuse, severe medical conditions, history of bad reactions when stopping antidepressants, eye conditions that limit light therapy use, or those using certain medications can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive light therapy or negative ion therapy while tapering off antidepressants
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Light therapy
- Negative ion therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Ontario Brain Institute
Collaborator
Centre for Addiction and Mental Health
Collaborator
University of Toronto
Collaborator
Université de Montréal
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
McMaster University
Collaborator